.png){kind=icon}
.png){kind=icon}
Return
News in autoimmune myelitis in the oncological context
.png){kind=icon}
PRE
AI
C
DOI：10.1097/WCO.0000000000001491.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Autoimmune myelitis represents a heterogeneous group of disorders whose classification has evolved substantially over the past decade. Advances in antibody diagnostics and the widespread use of immune checkpoint inhibitors (ICIs) in oncology have reshaped current concepts, revealing mechanistic and clinical overlaps between antibody-mediated, paraneoplastic, and treatment-induced myelopathies.
Keywords:
autoimmune myelitis
GFAP
immune checkpoint inhibitor
MOG
NMOSD
paraneoplastic
Journal
IF:
4.4
Papers:
2.8K
Citations:
6.5K
Organization
No organization information available
Cited Papers